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Abstract: A novel non-hemorrhagic basic metalloprotease, rubelase, was isolated from the 
venom of Crotalus ruber ruber. Rubelase hydrolyzes succinyl-L-alanyl-L-alanyl-L-alanyl 
p-nitroanilide (STANA), a specific substrate for elastase, and the hydrolytic activity was 
inhibited  by  chelating  agents.  It  also  hydrolyzes  collagen  and  fibrinogen.  However, 
hemorrhagic  activity  was  not  observed.  By  ESI/Q-TOF  and  MALDI/TOF  mass 
spectrometry combined with Edman sequencing procedure, the molecular mass of rubelase 
was determined to be 23,266 Da. Although its primary structure was similar to rubelysin 
(HT-2),  a  hemorrhagic  metalloprotease  isolated  from  the  same  snake  venom,  the 
circumstances surrounding putative zinc binding domain HEXXHXXGXXH were found to 
be different when the three-dimensional computer models of both metalloproteases were 
compared.  The  cytotoxic  effects  of  rubelase  and  rubelysin  on  cultured  endothelial  and 
smooth muscle cells were also different, indicating that the substitution of several amino 
acid residues causes the changes of active-site conformation and cell preference. 
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1. Introduction 
Many kinds of enzymes and biologically active peptides are present in snake venoms. Hemorrhage is 
one of the characteristic symptoms associated with Viperidae snake envenomation. In case of severe 
envenomation, hemorrhage can take place in many internal organs [1,2]. Several investigators have 
reported the purification, characterization, and structure of hemorrhagic principles from the venom of 
Protobothrops  flavoviridis  [3],  Protobothrops  mucrosquamatus  [4],  Deinagkistrodon  acutus  [5], 
Crotalus  atrox  [6,7], Crotalus ruber  ruber  [8] and Agkistrodon  bilineatus  [9]. These  investigators 
demonstrated  that  these  hemorrhagic  toxins  have  proteolytic  activity  capable  of  hydrolyzing  the 
oxidized insulin B chain, fibrinogen,  glucagon, and hide powder azure. The primary structures of 
various hemorrhagic toxins have been determined [10–17] and crystal structures of some low molecular 
weight toxins have been reported [18–23]. Recently, these toxins have been categorized as snake venom 
metalloproteases (SVMPs), and classified as members of ADAMs proteins [24,25]. On the other hand, 
the presence of elastase in snake venoms has been discussed for many years, but the conclusion has not 
been reached. Early study on the venom of red diamond rattlesnake (C. r. ruber) indicated that two major 
size classes of proteases are present in the venom [26]. However, only hemorrhagic toxins have been 
well  studied.  In  this  paper,  we  report  the  isolation  and  biochemical  characterization  of  novel 
non-hemorrhagic elastase from the venom of Crotalus r. ruber. 
2. Materials and Methods 
Lyophilized  crude  venom  was  purchased  from  Miami  Serpentarium  Laboratories  (U.S.A.). 
TOYOPEARL
TM  HW-50  was  obtained  from  Tosoh  Co.,  Ltd.,  Japan,  and  CM-cellulose  was  from 
Whatman  Laboratory  (England).  Succinyl-L-alanyl-L-alanyl-L-alanine  p-nitroanilide  (STANA), 
glutaryl-L-alanyl-L-alanyl-L-prolyl-L-leucine  p-nitroanilide  (GAAPLNA),  and  succinyl-L-alanyl-L- 
prolyl-L-alanine p-nitroanilide (SAPANA) were the products of Peptide Institute Inc. (Japan). Casein 
and bovine fibrinogen  were supplied by Merck  Laboratories  and  Daiichi  Pure Chemicals  (Japan), 
respectively. Hide powder azure, azoalbumin, and azo-dye impregnated collagen were purchased from 
Sigma Chemical  Co.  Lysyl  endopeptidase and clostripain  were the products  of Roche. CPKII-test 
Wako
TM for creatine phosphokinase activity was supplied by Wako Pure Chemical Industries, Ltd. 
(Japan). Cryo-preserved human umbilical vein endothelial cells (HUVEC), human pulmonary artery 
endothelial cells (HPAEC), human aortic smooth muscle cells (HASMC), and their respective cell 
culture medium were obtained from Kurabo (Japan). Cell counting kit-8
TM and CellTracker
TM green 
fluorescent  probe  CMFDA  (5-chloromethylfluororescein  diacetate)  were  supplied  by  Dojindo 
laboratories (Japan) and Lonza (USA), respectively. 
2.1. Isolation and Biochemical Properties 
Rubelase was isolated from crude venom by HW-50 gel filtration and CM-cellulose cation-exchange 
column chromatography (see Figure 1). The molecular weight was determined by SDS-polyacrylamide 
gel electrophoresis and nano ESI-MS using a Micromass Q-TOF mass spectrometer and MassLynx data 
acquisition.  The  mass  spectrometer  was  operated  in  the  positive-ion  mode.  Purified  sample  was 
extensively dialyzed against water, lyophilized and then dissolved at a protein concentration of 10 μM in Toxins 2011, 3                       
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a solution containing equal amounts of acetonitrile and 0.2% formic acid. Two microliters of the sample 
solution was loaded into a nanoflow tip. A flow rate of about 50 nL/min into the analyzer was produced 
as a result of a potential of 1.2 kV applied to the nanoflow tip in the ion source. The cone voltage was set 
to 50 V. The spectra were averaged, smoothed, centroided and deconvoluted. 
2.2. Enzyme Activities and Pharmacological Activities 
Elastase activity was assayed by the method of Hasegawa et al. [27] using STANA as the substrate. 
Proteolytic activity was measured by the method of Murata et al. [28] using casein as the substrate, and 
fibrinogenolytic activity was determined by the method of Ouyang and Teng [29]. Other enzyme assays 
were carried out as follows: arginine ester hydrolytic activity by the method of Roberts [30]; hide 
powder azure hydrolytic activity by the method of Rinderknecht [31]; azoalbumin hydrolytic activity by 
the method of Charney and Tomarelli [32]; azocollagen hydrolytic activity by the method of Moore [33]. 
One unit of STANA hydrolase activity was defined as the amount of enzyme that hydrolyzed 1 µM of 
substrate per min. The units of other enzyme activities were obtained by means of the following formula: 
units/mg = (absorbance change per min) ×  2/mg of protein. Hemorrhagic activity was determined by the 
method of Bjarnason and Tu [6], and serum creatine phosphokinase activity was measured by the 
method based on the procedure of Tanzer and Gilvarg [34]. 
2.3. Determination of Primary Structure and Computer Modeling 
Rubelase  was  enzymatically  digested  with  clostripain  and  lysyl  endopeptidase.  The  digested 
fragments were also obtained by autoproteolysis, which occurs when rubelase is incubated with EGTA at 
a molar ratio of 1:10. The fragments were analyzed by the combination of Edman degradation method 
and MALDI/TOF mass spectrometry. Applied Biosystems 491 protein sequencer and Model 610A PTH 
analyzer were used for the sequence analysis in accordance with the manufacturer’s instructions. The 
molecular mass of digested fragments was also confirmed by using Voyager
TM (Applied Biosystems). 
Lyophilized fragments were dissolved at a concentration of 10 µM in 0.1% trifluoroacetic acid (TFA) 
and mixed with matrix (10 mg/mL of α-cyano-4 hydroxy cinnamic acid in 70% acetonitrile cont. 0.1% 
TFA). The sample mixture was then applied onto a sample plate and analyzed. MOE
TM (a molecular 
simulation and modeling software; purchased from Chemical Computing Group Inc.) was used for 
construction of protein models. 
2.4. Toxicity Test on Cultured Cells 
Frozen human endothelial cells (HUVEC and HPAEC) and aortic smooth muscle cells (HASMC) 
were cultured and maintained in the appropriate medium according to the method of the suppliers’ 
instructions. For bioassays, cells were seeded at a density of 1.5 ×  10
4 cells/well in 0.1 mL of medium in 
96-multiwell plates. Samples were diluted in saline and then added to the cells. After 18 h, cell densities 
were determined by the colorimetric method using a cell counting kit-8 that was based on the tetrazolium 
salt/formazan system [35]. Cell staining was performed against the adherent cells on glass-plate dishes. 
Fluorescent probe CMFDA (0.5 µM in serum-free medium) was used according to the manufacturer’s 
manual, and the viable cells were observed under a fluorescence microscope. Toxins 2011, 3                       
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3. Results and Discussion 
3.1. Isolation and Properties 
Crude venom was fractionated using HW-50 column and elastase activity was found in fraction 6 
(Figure  1A). The  fraction was further  purified using CM-cellulose column chromatography  and a 
homologous preparation was found in fraction 2 (Figure 1B). The purified enzyme was named rubelase 
and the yield of rubelase from 69 mg crude venom was found to be approximately 5.3 mg. 
Figure  1.  Isolation  of  rubelase  from  Crotalus  r.  ruber  venom  by  chromatography.  
(A) HW-50 gel filtration. Crotalus r. ruber crude venom (69 mg) was applied to a column 
(1.5 ×  100 cm) equilibrated with 0.01 M Tris-HCl buffer (pH 7.2) containing 0.01 M NaCl. 
Fractions of 3.0 mL were collected at a flow rate of 10.8 mL/h; (B) CM-cellulose column 
chromatography.  The  enzyme  (fraction  6)  was  applied  to  a  column  (1.5  ×  45  cm) 
equilibrated with the same buffer, and eluted with a linear gradient from 0.01 to 0.5 M NaCl.  
 
When STANA, GAAPLNA and SAPANA were used as elastase substrate, rubelase preferentially 
hydrolyzed STANA (4.22 units/mg). Rubelase also possessed hydrolytic activities on hide powder azure 
(1.68 units/mg), azocollagen (1.18 units/mg) and azoalbumin (0.37 units/mg), and fibrinogenolytic 
activity (Aα and Bβ chains were hydrolyzed without forming fibrin clot). However, casein and arginine 
ester hydrolytic activities were not observed. Hemorrhagic activity was not detected when the purified 
enzyme (12 µg: approximately 40-times higher dose of minimum hemorrhagic dose of rubelysin) was 
injected s.c. into mice. Smooth muscle-damaging activity on mice, which was demonstrated as creatine 
phosphokinase activity in serum, was not detected, either. 
Rubelase was thermolabile and the elastase activity was completely lost after incubation for 10 min at 
60 ° C.  The  chelating  reagents  such  as  EDTA  and  EGTA  also  affected  elastase  activity  at  final 
concentrations of 0.1–0.5 mM. 
The isoelectric point was determined to be 9.2 by electrophoresis. The molecular mass of rubelase 
determined by SDS-PAGE was found to be 24,000 Da, while the ESI/Q-TOF mass method gave a 
molecular weight of 23,266 Da (Figure 2). The peak of 23,394 Da found in the macromolecule area 
indicates that there may be a macromolecule corresponding to rubelase with one residue, such as Lys and Toxins 2011, 3                       
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Glu, attached to its C-terminus. Since this point could be clarified by determining a complete gene 
sequence, analysis will be attempted if the venom glands of Crotalus r. ruber are obtained. 
Figure  2.  ESI/Q-TOF  mass  spectra  of  rubelase  from  Crotalus  r.  ruber  venom. 
SDS-polyacrylamide gel electrophoresis (insert). 
 
3.2. Primary Structure 
The  enzymatically  cleaved  fragments  of  rubelase  by  lysyl  endopeptidase  and  clostripain  were 
subjected to Edman sequencing analysis and MALDI/TOF mass spectrometry. The fragments produced 
by autoproteolysis of rubelase were also analyzed. Although the N-terminal amino acid of rubelase could 
not be detected by a direct sequence analysis of the intact enzyme, analysis of mass spectra of fragments 
revealed that it was L-pyroglutamic acid. By combining all the data, the complete amino acid sequence 
of rubelase was determined (Figure 3); rubelase is composed of 202 amino acids. The molecular mass of 
rubelase based on the amino acid sequence (23267.73 Da) was almost identical to the molecular mass 
(23,266 Da) obtained by ESI/Q-TOF mass spectra. 
3.3. Comparison of Rubelase and Rubelysin (HT-2) 
The  amino  acid  sequence  of  rubelase  is  extremely  homologous  to  rubelysin,  a  hemorrhagic 
metalloproteinase previously isolated from Crotalus r. ruber venom and named HT-2 [8,13]. The amino 
acid residues of rubelysin (HT-2) at the position of 81 (Trp), 87 (Leu), 114 (Asn), and 151 (Glu) are 
substituted for Val, Lys, Lys, and Lys in rubelase, respectively. Rubelysin possesses caseinolytic activity 
and its minimum hemorrhagic dose (M.H.D) has been determined to be 0.27 µg, whereas rubelase is a 
non-hemorrhagic  protein  and  does  not  hydrolyze  casein.  Since  the  putative  zinc  binding  domain 
HEXXHXXGXXH in both enzymes is completely conserved, substitutions of four amino acid residues 
might cause the difference of substrate preference and biological activity.  
3.4. Comparison of Rubelase with the Low Molecular Weight Metalloproteinases 
Various low molecular weight metalloproteinases were purified from snake venoms [6,13,36–38]. Toxins 2011, 3                       
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The sequence alignment shown in Figure 3 indicates that rubelase is a member of family of snake venom 
metalloproteinases (SVMPs). Of these enzymes, adamalysin II (EC 3.4.24.46) isolated from the venom 
of Crotalus adamanteus and H2-proteinase from the venom of Protobothrops flavoviridis are basic 
enzymes which have been shown not to exhibit significant hemorrhagic activity [36,38]. Since these 
properties are similar to rubelase, a significant difference in the caseinolytic activity exists between 
rubelase and these non-hemorrhagic metalloproteinases. 
Figure 3. Comparison of the amino acid sequence of rubelase with several low molecular 
weight  metalloproteinases  from  snake  venoms.  <E  denotes  L-pyroglutamic  acid.  The 
putative zinc binding ligand and the catalytic domain are indicated by ▲. 
 
3.5. Toxicity on Cultured Cells 
The effect of rubelase on cultured cells was investigated and  compared with that of  rubelysin.  
Figure 4 shows the changes in cell numbers after incubation with samples. Compared with control cells 
(white  bars),  viable  HUVEC,  HPAEC  and  HASMC  numbers  clearly  decreased  after  addition  of 
rubelysin, a hemorrhagic metalloproteinase (light blue bars). When 0.5 µg of rubelysin was added to 
HUVEC and HPAEC (Figure 4A,B), the number of viable cells decreased to similar levels as seen in the 
positive control (a cytotoxic control measured by using crude venom: green bars). On the other hand, 
rubelase possessed cytotoxicity only on HUVEC and HPAEC (Figure 4A,B: light yellow bars), and the Toxins 2011, 3                       
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effects were relatively weak as compared with rubelysin. The cytotoxic effects of rubelase and rubelysin 
on  endothelial  cells  (HPAEC)  were  visualized  as  the  cell  density  observed  under  a  fluorescence 
microscope (Figure 5). The viability of HASMC was not affected by rubelase (Figure 4C). These results 
indicate that rubelase does not inflict an injury on smooth muscle cells which compose blood vessels and 
tissues. Therefore, rubelase may cause neither hemorrhage nor muscular damage. The muscle damaging 
activity measured as serum CPK levels also supports this speculation. However, although rubelase is 
non-hemorrhagic in nature, it clearly possesses cytotoxicity on endothelial cells (Figure 5C) when 
directly in contact with cells. Rubelase might exhibit its toxicity only when it enters directly into the 
bloodstream by envenomation. 
Figure 4. Cytotoxic effects of rubelase and rubelysin on cultured cells. (A) HUVEC: human 
umbilical vein endothelial cells; (B) HPAEC: human pulmonary artery endothelial cells;  
(C) HASMC: human aortic smooth muscle cells. Rubelase and rubelysin were added to the 
cells at various concentrations. After incubation for 18 h, viable cells were counted using the 
colorimetric method. The results shown represent the average of five experiments. The 
absorbance of cultured cells incubated with saline or crude venom (10 µg) was defined as 
control and (cytotoxic) positive control *, respectively.  
 
Figure 5. Fluorescence micrographs of HPAEC (× 60) after incubation with rubelase and 
rubelysin. Control cells (A); and the cells incubated with rubelase (B); and rubelysin (C). 
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3.6. Molecular Modeling of Rubelase 
For molecular modeling of rubelase and rubelysin, the information on adamalysin II obtained from 
the Protein Data Bank (PDB) was referred to, since this protein is the most homologous to these enzymes. 
Figure 6A shows the protein models of rubelase and rubelysin with the positions of substituted amino 
acid residues and zinc binding domain. Comparing with rubelysin, the environment surrounding the zinc 
binding  domain  (His-Glu-Xxx-Xxx-His-Xxx-Xxx-Gly-Xxx-Xxx-His)  of  rubelase  seem  to  be  basic 
because of the substitutions of Asn (114) to Lys and Glu (151) to Lys (Figure 6B). These changes may 
cause the distortion of the zinc binding site in the active pocket, resulting in the decrease in the substrate 
recognition ability of rubelase against large substrates (e.g., casein). 
Figure  6.  Molecular  models  of  rubelase  and  rubelysin  with  the  zinc  binding  site  and 
substituted amino acid residues (A); and views of the surrounding structure of the zinc 
binding site (B). 
 
 
4. Conclusions 
A novel non-hemorrhagic metalloprotease, rubelase, hydrolyzes a specific substrate for elastase, and 
possesses  proteolytic  activity  on  collagen  and  fibrinogen.  Its  primary  structure  is  similar  to  the 
hemorrhagic metalloprotease, rubelysin. However, the cytotoxic effects of rubelase on cultured smooth 
muscle cells were relatively weak. The three-dimensional computer models of rubelase and rubelysin 
indicated that the circumstances surrounding zinc binding domain HEXXHXXGXXH were different. Toxins 2011, 3                       
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The substitution of several amino acid residues might cause the different cell preference and affect 
cytotoxicity and hemorrhagic activity. Hereafter, the mechanism of unique action of rubelase on vascular 
endothelial  cells  should  be  assessed,  also  taking  the  possibility  of  apoptosis  inductive  action  into 
consideration. Furthermore, if the venom glands of Crotalus r. ruber are obtained, analysis of the gene 
sequences that code for rubelase and rubelysin will be attempted. 
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